🇺🇸 FDA
Patent

US 6762032

Compositions, assay kits, and methods for use related to a disease condition comprising multiple sclerosis and/or a pro-MS immune response

expired A61KA61K2039/505A61K39/39541

Quick answer

US patent 6762032 (Compositions, assay kits, and methods for use related to a disease condition comprising multiple sclerosis and/or a pro-MS immune response) held by BioCrystal, Ltd. expires Mon Jul 08 2024 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
BioCrystal, Ltd.
Grant date
Tue Jul 13 2004 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 08 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
44
CPC classes
A61K, A61K2039/505, A61K39/39541